Vascular Ehlers-Danlos Syndrome
New vascular Ehlers-Danlos syndrome research, summarized each month in plain language.
2026 so far: So far in 2026 (January 2026 to September 2026), pregnancy planning and emergency-care decisions were the most common vEDS updates, while celiprolol follow-up stayed mixed and ciprofloxacin raised an animal-model rupture risk signal. Read the 2026 review
We also cover clinical trials.
Yearly update
2026 so far
- Celiprolol over time. Routine-care follow-up added nuance, not definitive benefit evidence.
- Pregnancy monitoring. Pregnancy reports shifted from small series to broader synthesis.
- Emergency care choices. Case reports and reviews highlighted tailored procedures and tradeoffs.
- Antibiotic safety signal. Preclinical work added a specific drug-exposure risk signal.
- Who is at risk. Cohort patterns and case-based recognition challenges became clearer.
New
September 2026
- Care coordination. Reviews stressed planned, team-based care to limit avoidable harm.
- COL3A1 testing. COL3A1 genetic testing was used to confirm suspected vEDS.
- Preterm birth risk. Preterm birth was often reported, but rates varied widely.
- Fetal vEDS link. Early membrane rupture was strongly linked to fetal vEDS status.
August 2026
- Imaging findings. Imaging found several aneurysms after a pulsating neck mass.
- Genetic test result. A COL3A1 variant confirmed vEDS in a pregnancy emergency.
- Splenic rupture. One case report described splenic rupture with severe bleeding.
July 2026
- Coronary tear care. Some coronary artery tears improved with medical treatment alone.
- Aortic bleeding. A teen had life-threatening aortic bleeding needing urgent open surgery.
- COL3A1 finding. A newly reported COL3A1 variant supported a vEDS diagnosis.
- Skin collagen patterns. Skin collagen imaging differed by person and is not validated.
June 2026
- Ciprofloxacin risk signal. In vEDS mice, ciprofloxacin was linked to more artery ruptures.
- Weaker aorta tissue. In mice, ciprofloxacin exposure was linked to lower aortic collagen.
- Post-surgery clot case. One report described a coronary clot after major aortic surgery.
- Lung and skin signs. Case reports described collapsed lungs and an unusual skin-hardening pattern.
May 2026
- Celiprolol outcomes over time. In follow-up reports, some people taking celiprolol still had vascular events during later years.
- Unexpected paths to diagnosis. Some vEDS diagnoses began after lung imaging findings or a brain blood-vessel event.
- Examples of emergency care. Case reports described endovascular coil treatment to control bleeding and cautious supportive care for temporary heart weakness.
- Measuring collagen in images. A new open-source image tool aimed to make collagen fiber measurements more consistent in research samples.
April 2026
- Aorta size in pregnancy. In a small, closely monitored pregnancy series, aortic measurements stayed fairly stable.
- Pregnancy complications. Even with stable aorta measurements, obstetric complications were common in this series.
- Lung bleeding on imaging. In a case report, unusual lung findings were interpreted as bleeding in the lungs related to vessel fragility.
- Hormone receptors in mice. In a vEDS mouse model, hormone receptor pathways were linked to rupture risk, but this has not been shown in people.
March 2026
- Imaging can look typical. In reported cases, SCAD linked to vEDS often looked typical on coronary imaging.
- Age and sex pattern in reports. In published SCAD-vEDS case reports, patients were often younger and more often male than in typical SCAD groups.
- Complications after aortic stent. One reported thoracic aortic stent case in vEDS had severe complications later on.
- Exercise after dissection. One case report described a structured low- to moderate-intensity exercise program after artery dissection that was feasible and linked to fitness gains.
February 2026
- TEVAR outcomes in syndromic aortopathy. In a national dataset, short-term complications and mid-term survival after TEVAR in syndromic genetic aortopathy were similar to non-syndromic cases, but the analysis was not specific to vascular Ehlers-Danlos syndrome.
- Patient-derived COL3A1 cell model. Researchers created matched human stem cell lines from one person with a COL3A1 variant and a gene-corrected version, and the vEDS-derived vascular smooth muscle cells showed internal structural differences mainly useful for lab studies.
January 2026
- Men: aorta and abdomen. Men more often had aorta and abdominal artery problems.
- Women: head and heart. Women more often had carotid-cavernous fistula or SCAD.
- Aortic surgery case. One case described open aortic replacement and later kidney-artery narrowing.
Get the monthly update by email
Subscribe here to receive an email when a new monthly vascular Ehlers-Danlos syndrome update is published. You can unsubscribe at any time. Your address is used for this only; delivery is handled by MailerLite (privacy policy).